Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6771038

Nc1nccc2ccc(OCCCNC(=O)c3ccc(OC4CCNCC4)cc3)cc12.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 3/20 0.48
DYRK1A Q13627 5/20 0.43
GSK3B P49841 4/20 0.43
F10 P00742 3/20 0.42
CHEK2 O96017 2/20 0.39
MET P08581 2/20 0.39
F7 P08709 1/20 0.39
WNT1 P04628 3/20 0.38
REN P00797 1/20 0.38
F2 P00734 1/20 0.37
ROCK2 O75116 1/20 0.37
KCNH2 Q12809 1/20 0.37
ENPP2 Q13822 1/20 0.37
LMNA P02545 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6771145 0.98 ROCK1 (0.48) ROCK1DYRK1AGSK3BF10CHEK2
Trifluoroacetic Acid SCHEMBL6775615 0.87 F10 (0.60) F10F2LMNAOPRM1OPRD1
Trifluoroacetic Acid SCHEMBL6770954 0.84 F10 (0.63) F10F7F2
Trifluoroacetic Acid SCHEMBL6769158 0.83 ROCK1 (0.45) ROCK1DYRK1AGSK3BF10CHEK2
Trifluoroacetic Acid SCHEMBL6775232 0.81 RAD52 (0.42) F10F7
Trifluoroacetic Acid SCHEMBL6769129 0.81 F10 (0.53) F10F2
Trifluoroacetic Acid SCHEMBL6890249 0.80 F10 (0.49) ROCK1F10
Trifluoroacetic Acid SCHEMBL6770182 0.79 NPC1 (0.42) F10
Trifluoroacetic Acid SCHEMBL6765882 0.78 F10 (0.56) F10F2
Trifluoroacetic Acid SCHEMBL3896028 0.78 F10 (0.68) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825181-B1 ORALLY ADMINISTRATED TO EXHIBIT A STRONG ANTICOAGULANT EFFECT BY INHIBITING ACTIVATED BLOOD- COAGULATION FACTOR X AJINOMOTO CO., INC. (JP) 2004-11-30 US disclosed
EP-1065200-A1 AMINOISOQUINOLINE DERIVATIVES Ajinomoto Co., Inc. (JP) 2001-01-03 EP disclosed